fosinopril has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belenkov, IuN; Belianko, IE; Dolotov, VK; Gerasimova, VV; Khovrin, VV; Konstantinov, BA; Koroteev, AV; Kulagina, TIu; Mareev, VIu; Rebunenkov, GV; Sandrikov, VA; Skvortsov, AA; Sychev, AV; Tereshchenko, SN | 1 |
| Arnim-Barker, A; Hird, RB; Holzgrefe, HH; Koster, WH; Mukherjee, R; Powell, JR; Spinale, FG; Walker, JD | 1 |
2 other study(ies) available for fosinopril and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
[Implantation of an extracardiac mesh in the treatment of dilated cardiomyopathy: the TOLK Study (Therapevticheskoe Operativnoe Lechenie Kardiomyopatye)].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diuretics; Female; Fosinopril; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Postoperative Care; Propanolamines; Quality of Life; Radiography, Thoracic; Spironolactone; Surgical Mesh; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents; Ventricular Remodeling | 2005 |
Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathy, Dilated; Cells, Cultured; Dogs; Female; Fosinopril; Heart Ventricles; Male; Microscopy, Electron; Muscle Contraction; Ventricular Function, Left | 1995 |